Input to public consultation on the Swiss Ordinance on Health Insurance

    5 Oct, 2016

    The RDAF provided input to the public consultation launched by the Federal Office of Public Health (FOPH) on the Swiss Ordinance on Health Insurance (KVV/OAMal). The RDAF’s input included action oriented suggestions for improving patient access to treatment and focused on aspects that are most important for the area of rare diseases such as the reimbursement process applying to individual cases (the so-called article 71 KVV reimbursement process).

    Continue reading

    The RDAF publishes its newsletter

    The newsletter, which is published twice a year, gives an overview of all the Rare Disease Action Forum (RDAF) activities during the past half year to raise awareness about rare diseases in Switzerland and improve patient’s access to diagnosis, treatment and care....

    RDAF 2022 General Assembly Meeting

    On 21 March 2022, the Rare Disease Action Forum (RDAF) held its annual General Assembly meeting. An overview of the RDAF’s activities in 2021 and an outlook for 2022 were presented. The RDAF President welcomed the new members and underlined that the collaborative...